A detailed history of Goepper Burkhardt LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Goepper Burkhardt LLC holds 3,655 shares of ABBV stock, worth $646,752. This represents 0.3% of its overall portfolio holdings.

Number of Shares
3,655
Previous 3,655 -0.0%
Holding current value
$646,752
Previous $626,000 15.18%
% of portfolio
0.3%
Previous 0.28%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $464 - $542
3 Added 0.08%
3,655 $626,000
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $32,922 - $37,512
206 Added 5.98%
3,652 $665,000
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $4,953 - $5,578
36 Added 1.06%
3,446 $534,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $267 - $309
2 Added 0.06%
3,410 $508,000
Q2 2023

Aug 16, 2023

SELL
$132.51 - $164.9 $13,118 - $16,325
-99 Reduced 2.82%
3,408 $459,000
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $144 - $166
1 Added 0.03%
3,507 $558,000
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $9,266 - $11,113
67 Added 1.95%
3,506 $566,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $17,581 - $20,164
-131 Reduced 3.67%
3,439 $462,000
Q2 2022

Aug 26, 2022

BUY
$137.62 - $174.96 $59,589 - $75,757
433 Added 13.8%
3,570 $547,000
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $107 - $135
1 Added 0.03%
3,137 $425,000
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $106 - $120
1 Added 0.03%
3,136 $338,000
Q2 2021

Jul 28, 2021

BUY
$105.21 - $117.21 $8,942 - $9,962
85 Added 2.79%
3,135 $353,000
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $19,641 - $21,623
192 Added 6.72%
3,050 $330,000
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $230,040 - $310,578
2,858 New
2,858 $306,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Goepper Burkhardt LLC Portfolio

Follow Goepper Burkhardt LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goepper Burkhardt LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goepper Burkhardt LLC with notifications on news.